Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib”

511 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 511 results

Testing effectiveness (Phase 2)UnknownNCT04590625
What this trial is testing

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zhongshan Hospital Xiamen University 58
Testing effectiveness (Phase 2)Ended earlyNCT03320629
What this trial is testing

Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Refractory or Metastatic Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 7
Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT05171309
What this trial is testing

Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 35
Testing effectiveness (Phase 2)Study completedNCT02945852
What this trial is testing

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Who this might be right for
Small Cell Lung Cancer
Fan Yun, MD 40
Large-scale testing (Phase 3)UnknownNCT04203485
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
PD-L1 Positive Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 762
Not applicableStudy completedNCT04814329
What this trial is testing

Glioblastoma Response Prediction to Apatinib

Who this might be right for
Glioblastoma
Beijing Sanbo Brain Hospital 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339281
What this trial is testing

Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Li Huiping 68
Testing effectiveness (Phase 2)UnknownNCT04014101
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02733107
What this trial is testing

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 25
Large-scale testing (Phase 3)Study completedNCT02711007
What this trial is testing

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Who this might be right for
OsteosarcomaMetastasis
GUO WEI 37
Not applicableUnknownNCT04559607
What this trial is testing

TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 188
Testing effectiveness (Phase 2)UnknownNCT04089657
What this trial is testing

Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens

Who this might be right for
Advanced Metastatic Gastric Cancer
Fujian Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03104283
What this trial is testing

Apatinib for the Elderly Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Affiliated Hospital of Qinghai University 48
Testing effectiveness (Phase 2)UnknownNCT04239443
What this trial is testing

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Who this might be right for
Advanced Non Small Cell Lung CancerUterine CancerSoft Tissue Sarcoma
Hunan Cancer Hospital 120
Large-scale testing (Phase 3)UnknownNCT02780778
What this trial is testing

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Not applicableUnknownNCT03255811
What this trial is testing

Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
DongMa 40
Testing effectiveness (Phase 2)UnknownNCT04683198
What this trial is testing

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 69
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT03547804
What this trial is testing

A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
The First Hospital of Jilin University 31
Load More Results